BioHealth News

From Serbia and China to College Park – Maryland Today

From Serbia and China to College Park – Maryland Today

When husband and wife Zairen Sun Ph.D. ’98 and Beibei Li Ph.D. ’98 arrived in College Park from China in 1992, they had little…

Read More
U.S. FDA Approves Over-the-Counter Designation for Emergent BioSolutions’ NARCAN® Nasal Spray, a Historic Milestone for the Opioid Overdose Emergency Treatment

U.S. FDA Approves Over-the-Counter Designation for Emergent BioSolutions’ NARCAN® Nasal Spray, a Historic Milestone for the Opioid Overdose Emergency Treatment

NARCAN® Naloxone HCl Nasal Spray 4 mg is currently the first and only prescription strength naloxone nasal spray to receive over-the-counter status in the U.S., which…

Read More
Gaithersburg’s Salubris Biotherapeutics Announces $35 Million Financing to Advance Development Activities and Provides Pipeline Updates

Gaithersburg’s Salubris Biotherapeutics Announces $35 Million Financing to Advance Development Activities and Provides Pipeline Updates

MARCH 28, 2023 - GAITHERSBURG, Md., (BUSINESS WIRE) -- Salubris Biotherapeutics, Inc. (SalubrisBio), a clinical-stage biotechnology company dedicated to discovering and developing novel complex…

Read More
MIMETAS and Astellas Enter into Strategic Partnership on Immuno-Oncology

MIMETAS and Astellas Enter into Strategic Partnership on Immuno-Oncology

Leiden, the Netherlands , March 28, 2023 / B3C newswire / -- MIMETAS, a global leader in human disease modeling announces that it has entered…

Read More
Exploring the Reversal of Cancer Resistance: A BioTalk Podcast Discussion with Vishal Doshi of AUM Biosciences

Exploring the Reversal of Cancer Resistance: A BioTalk Podcast Discussion with Vishal Doshi of AUM Biosciences

Ready to explore the frontiers of cancer therapeutics? Discover how AUM Biosciences, with a key presence in Montgomery County, Maryland, in the BioHealth Capital…

Read More
MacroGenics Earns $15 Million Milestone Following U.S. FDA Approval of ZYNYZ™ (retifanlimab-dlwr)

MacroGenics Earns $15 Million Milestone Following U.S. FDA Approval of ZYNYZ™ (retifanlimab-dlwr)

ROCKVILLE, MD, March 22, 2023 (GLOBE NEWSWIRE) --  MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative antibody-based therapeutics for the treatment…

Read More
BioBuzz and FITCI Announce Strategic Partnership · BioBuzz

BioBuzz and FITCI Announce Strategic Partnership · BioBuzz

MARYLAND, March 23, 2023 — BioBuzz, the media outlet of Workforce Genetics, and the Frederick Innovative Technology Center, Inc. (FITCI) have announced a strategic…

Read More
Washington Must Wake Up To The Innovation Imperative

Washington Must Wake Up To The Innovation Imperative

There has been a smoldering fire on the geopolitical stage that, if we continue to ignore, we risk allowing it to spread and burn…

Read More
ARPA-H Hosts Proposers’ Day to Promote Funding Opportunities for Groundbreaking Health Research

ARPA-H Hosts Proposers’ Day to Promote Funding Opportunities for Groundbreaking Health Research

Event provides forum for researchers to learn more about ARPA-H’s Open Broad Agency Announcement ARPA-H has opened its first Agency-wide Open BAA, seeking funding…

Read More
Advancing Life Sciences Innovation: BioBuzz Collaborates with Frederick Innovative Technology Center, Inc. (FITCI) Announce Strategic Partnership

Advancing Life Sciences Innovation: BioBuzz Collaborates with Frederick Innovative Technology Center, Inc. (FITCI) Announce Strategic Partnership

  MARYLAND, March 23, 2023 — BioBuzz, the media outlet of Workforce Genetics, and the Frederick Innovative Technology Center, Inc. (FITCI) have announced a…

Read More
The Board of Children’s National selects Michelle Riley-Brown, MHA, FACHE, as its next president and CEO

The Board of Children’s National selects Michelle Riley-Brown, MHA, FACHE, as its next president and CEO

Riley-Brown will succeed Kurt Newman, M.D., who has served in role for over 11 years March 23, 2023 The Children’s National Board of Directors…

Read More

How Vishal Doshi Is Turning Cancer Into A Manageable Lifestyle Disease | a+: At The Vanguard

Whenever someone asks about dreams, there is an underlying expectation that it is something that springs up on you at a nascent age, like…

Read More
Start to build relationships with investors now, even if you’re not in an active fundraising round | LinkedIn

Start to build relationships with investors now, even if you’re not in an active fundraising round | LinkedIn

At Johnson & Johnson Innovation – JLABS, part of our mission is to bring big company benefits to entrepreneurs and startups, along with our…

Read More
MIMETAS Achieves Important Milestones in Partnership with Roche

MIMETAS Achieves Important Milestones in Partnership with Roche

Leiden, March 3, 2023 – MIMETAS has achieved major milestones in its partnership with Roche, developing models for Inflammatory Bowel Disease (IBD) and Hepatitis…

Read More
BioHealth Capital Region Shines as DC, Maryland, and Virginia Secure Top 10 Spots in WalletHub’s Most Innovative States Rankings

BioHealth Capital Region Shines as DC, Maryland, and Virginia Secure Top 10 Spots in WalletHub’s Most Innovative States Rankings

March 22, 2023 - The BioHealth Capital Region (BHCR) with The District of Columbia, Maryland, and Virginia are making a name for themselves as…

Read More